BioAsia&微软&安永：2025年人工智能对生命科学领域的革命性影响研究报告（英文版）

The life sciences sector is experiencing a transformative evolution driven by artificial intelligence (AI), with significant implications across pharmaceutical, biotechnology, medical technology (MedTech) sectors and academic medical centers (AMCs). The global AI market demonstrates substantial growth potential, with AI in pharmaceuticals sector expected to reach to US$16.49 billion by 2034, driven by AI’s transformative impact on drug discovery, clinical trials and personalized healthcare. S